Possible mechanism of action of transfusion effect in renal-transplantation

Alison Murray MacLeod, R. J. Mason, W. G. Shewan, D. A. Power, Keith Nicol Stewart, N. Edward, G. R. D. Catto

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The mechanism by which blood transfusions given before renal transplantation improves allograft survival was studied in 31 transplant recipients. The presence of non-cytotoxic, Fc receptor blocking antibodies to donor and leukaemic B lymphocytes in pre-transplant sera correlated with both improved graft survival (p<0 ·03 and <0·1, respectively) and the number of blood transfusions given (p<0 ·05 and <0 ·03, respectively). Moreover, 6 out of 10 previously untransfused prospective transplant recipients developed these potentially protective antibodies during a course of elective blood transfusions. These results indicate that such non-cytotoxic, Fc receptor blocking antibodies in pretransplant recipient sera (a) are associated with improved allograft survival, (b) correlate with the number of blood transfusions given, and (c) can develop in response to blood transfusion.

Original languageEnglish
Pages (from-to)468-470
Number of pages3
JournalThe Lancet
Volume2
Issue number8296
DOIs
Publication statusPublished - 28 Aug 1982

Cite this

MacLeod, A. M., Mason, R. J., Shewan, W. G., Power, D. A., Stewart, K. N., Edward, N., & Catto, G. R. D. (1982). Possible mechanism of action of transfusion effect in renal-transplantation. The Lancet, 2(8296), 468-470. https://doi.org/10.1016/S0140-6736(82)90496-2

Possible mechanism of action of transfusion effect in renal-transplantation. / MacLeod, Alison Murray; Mason, R. J. ; Shewan, W. G. ; Power, D. A. ; Stewart, Keith Nicol; Edward, N. ; Catto, G. R. D. .

In: The Lancet, Vol. 2, No. 8296, 28.08.1982, p. 468-470.

Research output: Contribution to journalArticle

MacLeod, AM, Mason, RJ, Shewan, WG, Power, DA, Stewart, KN, Edward, N & Catto, GRD 1982, 'Possible mechanism of action of transfusion effect in renal-transplantation', The Lancet, vol. 2, no. 8296, pp. 468-470. https://doi.org/10.1016/S0140-6736(82)90496-2
MacLeod AM, Mason RJ, Shewan WG, Power DA, Stewart KN, Edward N et al. Possible mechanism of action of transfusion effect in renal-transplantation. The Lancet. 1982 Aug 28;2(8296):468-470. https://doi.org/10.1016/S0140-6736(82)90496-2
MacLeod, Alison Murray ; Mason, R. J. ; Shewan, W. G. ; Power, D. A. ; Stewart, Keith Nicol ; Edward, N. ; Catto, G. R. D. . / Possible mechanism of action of transfusion effect in renal-transplantation. In: The Lancet. 1982 ; Vol. 2, No. 8296. pp. 468-470.
@article{524e9550001a487aa0d75f1561688805,
title = "Possible mechanism of action of transfusion effect in renal-transplantation",
abstract = "The mechanism by which blood transfusions given before renal transplantation improves allograft survival was studied in 31 transplant recipients. The presence of non-cytotoxic, Fc receptor blocking antibodies to donor and leukaemic B lymphocytes in pre-transplant sera correlated with both improved graft survival (p<0 ·03 and <0·1, respectively) and the number of blood transfusions given (p<0 ·05 and <0 ·03, respectively). Moreover, 6 out of 10 previously untransfused prospective transplant recipients developed these potentially protective antibodies during a course of elective blood transfusions. These results indicate that such non-cytotoxic, Fc receptor blocking antibodies in pretransplant recipient sera (a) are associated with improved allograft survival, (b) correlate with the number of blood transfusions given, and (c) can develop in response to blood transfusion.",
author = "MacLeod, {Alison Murray} and Mason, {R. J.} and Shewan, {W. G.} and Power, {D. A.} and Stewart, {Keith Nicol} and N. Edward and Catto, {G. R. D.}",
year = "1982",
month = "8",
day = "28",
doi = "10.1016/S0140-6736(82)90496-2",
language = "English",
volume = "2",
pages = "468--470",
journal = "The Lancet",
issn = "0140-6736",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "8296",

}

TY - JOUR

T1 - Possible mechanism of action of transfusion effect in renal-transplantation

AU - MacLeod, Alison Murray

AU - Mason, R. J.

AU - Shewan, W. G.

AU - Power, D. A.

AU - Stewart, Keith Nicol

AU - Edward, N.

AU - Catto, G. R. D.

PY - 1982/8/28

Y1 - 1982/8/28

N2 - The mechanism by which blood transfusions given before renal transplantation improves allograft survival was studied in 31 transplant recipients. The presence of non-cytotoxic, Fc receptor blocking antibodies to donor and leukaemic B lymphocytes in pre-transplant sera correlated with both improved graft survival (p<0 ·03 and <0·1, respectively) and the number of blood transfusions given (p<0 ·05 and <0 ·03, respectively). Moreover, 6 out of 10 previously untransfused prospective transplant recipients developed these potentially protective antibodies during a course of elective blood transfusions. These results indicate that such non-cytotoxic, Fc receptor blocking antibodies in pretransplant recipient sera (a) are associated with improved allograft survival, (b) correlate with the number of blood transfusions given, and (c) can develop in response to blood transfusion.

AB - The mechanism by which blood transfusions given before renal transplantation improves allograft survival was studied in 31 transplant recipients. The presence of non-cytotoxic, Fc receptor blocking antibodies to donor and leukaemic B lymphocytes in pre-transplant sera correlated with both improved graft survival (p<0 ·03 and <0·1, respectively) and the number of blood transfusions given (p<0 ·05 and <0 ·03, respectively). Moreover, 6 out of 10 previously untransfused prospective transplant recipients developed these potentially protective antibodies during a course of elective blood transfusions. These results indicate that such non-cytotoxic, Fc receptor blocking antibodies in pretransplant recipient sera (a) are associated with improved allograft survival, (b) correlate with the number of blood transfusions given, and (c) can develop in response to blood transfusion.

U2 - 10.1016/S0140-6736(82)90496-2

DO - 10.1016/S0140-6736(82)90496-2

M3 - Article

VL - 2

SP - 468

EP - 470

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8296

ER -